Peptides/Nanomedicine for AS

Using biocompatible and biodegradable peptides in nanomedicine for atherosclerosis provides targeting and therapeutic functionality that can assist in overcoming delivery barriers of traditional drugs and makes them attractive for in vivo use. Here is the latest research.

July 28, 2020
Review
Open Access

Emerging Roles for Neuropilin-2 in Cardiovascular Disease

International Journal of Molecular Sciences
Jennifer L HarmanCaroline Pellet-Many
August 1, 2020
Review

Benefits of Bisphosphonate Therapy: Beyond the Skeleton

Current Osteoporosis Reports
Emma O Billington, Ian R Reid
July 27, 2020
Open Access

Multiple functions of policosanol in elderly patients with dyslipidemia

The Journal of International Medical Research
Chunlin LiKun Xu
July 28, 2020

SRGN, a new identified shear-stress-responsive gene in endothelial cells

Molecular and Cellular Biochemistry
Qinfeng MaGuixue Wang
August 3, 2020

Long-acting GLP-1 receptor agonists: Findings and implications of cardiovascular outcomes trials

JAAPA : Official Journal of the American Academy of Physician Assistants
Scott Urquhart, Stephen Willis
August 1, 2020
Open Access

Colchicine Alleviates Cholesterol Crystal-Induced Endothelial Cell Pyroptosis through Activating AMPK/SIRT1 Pathway

Oxidative Medicine and Cellular Longevity
Mengyue YangBo Yu
July 23, 2020
Review

Inter-organ cross-talk in metabolic syndrome

Nature Metabolism
Christina Priest, Peter Tontonoz
August 2, 2020

Association between periodontitis and vascular endothelial function using noninvasive medical device-A pilot study

Clinical and Experimental Dental Research
Takahito FujitaniMasato Minabe
July 30, 2020

Plasma endothelial microvesicles and their carrying miRNA-155 serve as biomarkers for ischemic stroke

Journal of Neuroscience Research
Huiting ZhangXiaotang Ma
August 4, 2020
Review

An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning

Iranian Journal of Basic Medical Sciences
Maryam RameshradHossein Hosseinzadeh
July 23, 2020

The role of DNA hydroxymethylation in the regulation of atherosclerosis

Yi chuan = Hereditas
Ying Chu HuXiao Min Chen
August 1, 2020
Review

Polymer nanomedicines

Advanced Drug Delivery Reviews
Jindřich Kopeček, Jiyuan Yang
August 3, 2020

Salvianolic acid B ameliorates atherosclerosis via inhibiting YAP/TAZ/JNK signaling pathway in endothelial cells and pericytes

Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
Ying YangYunlun Li
July 27, 2020

Apolipoprotein M: Research Progress and Clinical Perspective

Advances in Experimental Medicine and Biology
Guanghua Luo, Ning Xu

Sign up to follow this feed and discover related papers.

Related Feeds

Adult Kidney Organoids at Single Cell Resolution

Single-cell RNA sequencing of the adult human kidney transcriptome can provide molecular information about cell-specific responses to environmental variables and disease states. This information can provide a dataset to benchmark human kidney organoids. Discover the latest research on adult kidney organoids at single cell resolution here.

Artificial Cell Models

This feed focuses on biomimetrics, synthetic biology and bio- and tissue-engineering approaches used for modeling human diseases.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Biomaterial Engineering

Advances in biomaterial engineering have permitted the development of sophisticated drug-releasing materials with a biomimetic 3D support that allow a better control of the microenvironment of transplanted cells. Here is the latest research.

Brain Organoids in Disease Modeling

Brain organoids are used to represent an in vitro model of the human brain. These brain organoids are derived from three-dimensional human pluripotent stem cells and can be used to help study brain biology, early brain development and different brain diseases. Discover the latest research on brain organoids in disease modeling here.

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR in Malaria

CRISPR-Cas system enables the editing of genes to create or correct mutations. This technology is being investigated to combat malaria by targeting specific stretches of vector DNA and editing the genome at precise locations. Here is the latest research.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

© 2020 Meta ULC. All rights reserved
/feed-previews/peptidesnanomedicine-for-as/de161280-50d7-4074-807b-41cc176138a3